Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2012 16:09 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. to Present at Robert W. Baird 2012 Health Care Conference

WALTHAM, Mass., Aug. 30, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...
August 30, 2012 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Publication of Important Galectin-3 Study Designed to Identify Adults in General Population at Risk for Heart Failure

WALTHAM, Mass., Aug. 30, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
August 09, 2012 08:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Fiscal 2012 Second Quarter Results

WALTHAM, Mass., Aug. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the three and six months ended June 30, 2012 and provided a...
August 02, 2012 18:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Second Quarter 2012 Financial Results Release Date and Conference Call Information

WALTHAM, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that its financial results for the second quarter of fiscal year 2012 will be released before market...
July 20, 2012 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces 510(k) Filing for the ARCHITECT Galectin-3 Assay on the Abbott ARCHITECT Automated Platform

WALTHAM, Mass, July 20, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced the...
July 09, 2012 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. to Present at the JMP Securities Healthcare Conference

WALTHAM, Mass., July 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
July 02, 2012 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Appoints Bill Densel, General Manager, CardioSCORE

WALTHAM, Mass., July 2, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
June 18, 2012 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Atherotech Diagnostics Lab

WALTHAM, Mass., June 18, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
May 15, 2012 07:00 ET | Source: BG Medicine, Inc.

BG Medicine Announces Fiscal 2012 First Quarter Results

WALTHAM, Mass., May 15, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the first quarter of fiscal year 2012 and provided a...
May 15, 2012 06:45 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Obtains CE Mark and Files 510(k) for Expanded BGM Galectin-3(TM) Indication

WALTHAM, Mass., May 15, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...